Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness

Description

Not available / text

Links & Downloads

1. b59058742
2. http://hdl.handle.net/2152/1271
3. 57663420
4. 3143479

Tags

Osteoporosis in women--Treatment

Osteoporosis in women--Risk factors

Osteoporosis in women--Epidemiology

Osteoporosis in women--Hormone therapy

Additional Fields

Identifer	oai:union.ndltd.org:UTEXAS/oai:repositories.lib.utexas.edu:2152/1271
Date	28 August 2008
Creators	Tiller, Kevin Wade
Source Sets	University of Texas
Language	English
Detected Language	English
Type	Thesis
Format	electronic
Rights	Copyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works.